{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct03529123",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct03529123",
  "name": "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)",
  "aliases": [
    "NCT03529123"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 247 participants.",
  "summary_technical": "Registry record NCT03529123. Randomized; no masking; primary purpose treatment. Start 2018-06-19 (actual); primary completion 2019-11-25 (actual). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-08",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT03529123",
      "normalized_value": "NCT03529123",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; no masking; primary purpose treatment",
    "drug_phase": "3",
    "registry_statuses": [
      {
        "status": "COMPLETED",
        "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
      }
    ],
    "start_date": {
      "date": "2018-06-19",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
    },
    "primary_completion_date": {
      "date": "2019-11-25",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
    },
    "completion_date": {
      "date": "2019-11-25",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "IN",
        "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 247,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct03529123-2022-04-25"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "INSULIN GLARGINE (HOE901)",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Metformin",
        "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Insulin Glulisine (HMR1964)",
        "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
      },
      {
        "label": "Lead sponsor",
        "value": "Sanofi",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "dc84ebb181c5a9ff36ef508e822193a882522da68e9832736a24415d10afc174",
  "review": {
    "content_digest": "dc84ebb181c5a9ff36ef508e822193a882522da68e9832736a24415d10afc174",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03529123-2022-04-25",
          "locator": "derivedSection.conditionBrowseModule.meshes[0].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as the lead sponsor",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-sanofi",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03529123-2022-04-25",
          "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
        },
        "primary": false,
        "role": "lead",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct03529123/",
  "context_path": "api/v1/context/cardio--ct-nct03529123.md"
}
